Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.

Item

http://www.wikidata.org/entity/Q38226402

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clofarabine for the treatment ...... hoblastic Leukemia intergroup.

@en

type

Item

label

Clofarabine for the treatment ...... hoblastic Leukemia intergroup.

@en

prefLabel

Clofarabine for the treatment ...... hoblastic Leukemia intergroup.

@en

P1476

Clofarabine for the treatment ...... hoblastic Leukemia intergroup.

@en

P2093

Arnaud Pigneux

http://www.w3.org/2001/XMLSchema#string

Emmanuel Raffoux

http://www.w3.org/2001/XMLSchema#string

Françoise Huguet

http://www.w3.org/2001/XMLSchema#string

Norbert Ifrah

http://www.w3.org/2001/XMLSchema#string

Norbert Vey

http://www.w3.org/2001/XMLSchema#string

Philippe Rousselot

http://www.w3.org/2001/XMLSchema#string

Thibaut Leguay

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.

A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome

FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma.

Salvage therapy for refractory or relapsed acute lymphocytic leukemia.

Discovery and development of clofarabine: a nucleoside analogue for treating cancer.

Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.

Recent progress in the treatment of acute lymphoblastic leukemia: clofarabine.

P304

847-857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2014.887708

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hervé Dombret

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24996442

http://www.w3.org/2001/XMLSchema#string

P921

leukemia